266 articles
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...
Breaking: Nationwide Recall of Chlorthalidone Tablets Raises Concerns for Hypertension Patients The U.S. Food and Drug Administration (FDA) has announced a voluntary nationwide recall of...
A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...
A major study of 600,000 veterans finds GLP-1 weight loss drugs like Ozempic may reduce addiction risk and opioid overdose by up to 40%. New hope for addiction treatment.
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Jaff, Vice President and Chief Medical Officer, Peripheral Interventions at Boston Scientific and Dr. Learn more on Health Professional Radio.
Trial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, di...
Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s...
Lee, MD, Cherng Family Director's Chair, Center for Integrative Oncology at City of Hope, one of the largest cancer research and treatment organizations...
KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical, part of the Meeting Protocol Worldwide family...